YU30103A - Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti - Google Patents

Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti

Info

Publication number
YU30103A
YU30103A YU30103A YUP30103A YU30103A YU 30103 A YU30103 A YU 30103A YU 30103 A YU30103 A YU 30103A YU P30103 A YUP30103 A YU P30103A YU 30103 A YU30103 A YU 30103A
Authority
YU
Yugoslavia
Prior art keywords
antiprogestins
prophylaxis
treatment
dependent diseases
hormone dependent
Prior art date
Application number
YU30103A
Other languages
English (en)
Inventor
Jens Hoffmann
Rosemarie Lichtner
Gerhard Siemeister
Martin Schneider
Ulrike Fuhrmann
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU30103A publication Critical patent/YU30103A/sh
Publication of RS50389B publication Critical patent/RS50389B/sr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ovaj pronalazak se odnosi na postupke i upotrebe za sprečavanje ili lečenje hormonski zavisne bolesti, posebno kancera dojke, kod sisara antiprogestinima, posebno antiprogestinom 11ГЎ-(4-acetilfenil)-17ГЎ-hidroksi-17α-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-onom ili njegovim farmaceutski prihvatljivim derivatom ili analogom. Pronalazak se dalje odnosi na farmacetuske sastave koji obuhvataju navedeni antiprogestin.[The present invention relates to methods and uses for preventing or treating hormone-dependent disease, in particular breast cancer, in a mammal by antiprogestins, in particular antiprogestin 11ГЎ-(4-acetylphenyl)-17ГЎ-hydroxy-17α-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a pharmaceutically acceptable derivative or analogue thereof. The invention further relates to pharmaceutical compositions comprising said antiprogestin.
YUP-301/03A 2000-10-18 2001-10-17 Upotreba antiprogestina za profilaksu i lečenje hormonskih zavisnih bolesti RS50389B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24098800P 2000-10-18 2000-10-18
EP00250341 2000-10-18

Publications (2)

Publication Number Publication Date
YU30103A true YU30103A (sh) 2006-08-17
RS50389B RS50389B (sr) 2009-12-31

Family

ID=34072454

Country Status (8)

Country Link
AR (1) AR032371A1 (sh)
EA (1) EA007529B1 (sh)
EC (1) ECSP034605A (sh)
PE (1) PE20020520A1 (sh)
RS (1) RS50389B (sh)
UA (1) UA75615C2 (sh)
UY (1) UY26965A1 (sh)
ZA (1) ZA200303793B (sh)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
AR032371A1 (es) 2003-11-05
UA75615C2 (en) 2006-05-15
PE20020520A1 (es) 2002-06-15
UY26965A1 (es) 2002-06-20
EA200300480A1 (ru) 2003-10-30
ECSP034605A (es) 2003-06-25
RS50389B (sr) 2009-12-31
EA007529B1 (ru) 2006-10-27
ZA200303793B (en) 2004-08-16

Similar Documents

Publication Publication Date Title
HRP20030387A2 (en) Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
EA200301022A1 (ru) Гормональная заместительная терапия
NO20056153L (no) Preparat omfattende antiprogestiner og rene antiostrogener for profylakse og behandling av hormon-avhengige sykdommer
YU30103A (sh) Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
EE200300157A (et) Antiprogestiinide kasutamine apoptoosi esilekutsumiseks rakus
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
RS50350B (sr) Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma